|
|
Transcripts that showed altered expression in cat-1(RNAi) animals comparing to control animals injected with empty vector. |
p-value <= 0.05 |
WBPaper00066902:cat-1(RNAi)_regulated
|
|
|
Transcripts that showed significantly decreased expression in eat-2(ad1116) comparing to in N2 at 3-days post L4 adult hermaphrodite animals. |
DESeq2(v1.14.1), fold change > 2, p-value < 0.05 |
WBPaper00055354:eat-2(ad1116)_downregulated
|
|
|
Transcripts that showed significantly increased expression in dpy-21(e428) comparing to in N2 during L3 stage. |
DESeq v1.6.3. Fold change > 1.5. |
WBPaper00050370:dpy-21(e428)_L3_upregulated
|
|
|
Transcripts that showed significantly decreased expression in whole animal day 1 N2 adults comparing to in whole animal day 8 N2 adults. |
DESeq2, FDR < 0.05, fold change > 2. |
WBPaper00066978:Day1Adult_vs_Day8Adult_downregulated_neuron
|
|
|
Transcripts that showed significantly decreased expression in ogt-1(ok1474) neuronal cells isolated by FACs comparing to in FACs isolated neuronal cells from wild type. |
DESeq2, fold change > 2, FDR < 0.05. |
WBPaper00066485:ogt-1(ok1474)_downregulated_neuron
|
|
|
Transcripts that showed significantly decreased expression in daf-2(e1370) comparing to in N2. |
Student's t-test, fold change > 2, p-value < 0.05. |
WBPaper00055386:daf-2(e1370)_downregulated
|
|
|
Transcripts that showed significantly increased expression in adr-1(tm668) comparing to in N2. |
DESeq2, p-value < 0.05 and a fold enrichment log2fold > 0.5. |
WBPaper00055226:adr-1(tm668)_upregulated
|
|
|
Genes that showed significantly increased expression in rpn-10(ok1865) comparing to in N2 animals |
Differentially expressed genes were then identified through the use of serial t-testing coupled with Benjamini-Hochberg correction and genes with an adjusted p-value score less than 0.05 were considered to be differentially expressed. |
WBPaper00049177:rpn-10(ok1865)_upregulated
|
|
|
Transcripts that showed significantly decreased expression after treated by 50uM CGP37157 (7-chloro-5-(2-chlorophenyl)-1,5-dihydro-4,1-benzothiazepin-2-one) for 5 days starting from young adult stage. |
DESeq fold change > 2, p-value < 0.05 |
WBPaper00061590:CGP37157_downregulated
|